The maxon group achieved revenues of 526.3 million Swiss francs in 2018, representing a growth of 14.7 percent over the previous year, according to a statement from the Obwalden-based specialists in electrical drive trains and systems.
In addition, every single sales company in the EMEA region (Europe, Middle East and Africa) set new revenue records last year. In the US, where maxon opened a new facility in Taunton, near Boston, in March, maxon also recorded its highest ever revenues. With 42 percent of the total sales, medical technology remains the most important market for maxon.
In 2018, maxon also invested more than 100 million francs of its own funds in its production sites in Sachseln in the canton of Obwalden, Sexau in Germany, Veszprém in Hungary, Cheonan in South Korea, and Taunton in the US.
“In 2019, we will continue investing heavily in research and development. We will continue with the digitalization process and further develop our global organizational structure,” said maxon CEO Eugen Elmiger.
Due to the uncertain overall business climate, maxon expects only moderate growth for the current business year. Nonetheless, its orders are currently up 5 percent from the previous year.
